Renaissance Technologies’s Marker Therapeutics MRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$106K Sell
69,442
-14,073
-17% -$21.5K ﹤0.01% 3290
2025
Q1
$103K Buy
83,515
+43,465
+109% +$53.5K ﹤0.01% 3198
2024
Q4
$125K Buy
40,050
+300
+0.8% +$933 ﹤0.01% 3253
2024
Q3
$112K Buy
39,750
+900
+2% +$2.54K ﹤0.01% 3242
2024
Q2
$211K Buy
38,850
+1,600
+4% +$8.69K ﹤0.01% 3029
2024
Q1
$160K Sell
37,250
-300
-0.8% -$1.29K ﹤0.01% 3276
2023
Q4
$207K Sell
37,550
-2,700
-7% -$14.9K ﹤0.01% 3122
2023
Q3
$183K Buy
40,250
+8,300
+26% +$37.7K ﹤0.01% 3116
2023
Q2
$99K Buy
31,950
+12,600
+65% +$39K ﹤0.01% 3476
2023
Q1
$14K Buy
19,350
+3,030
+19% +$2.19K ﹤0.01% 3865
2022
Q4
$43K Buy
16,320
+1,170
+8% +$3.08K ﹤0.01% 3825
2022
Q3
$56K Sell
15,150
-11,620
-43% -$43K ﹤0.01% 3727
2022
Q2
$88K Sell
26,770
-31,657
-54% -$104K ﹤0.01% 3879
2022
Q1
$257K Sell
58,427
-48,473
-45% -$213K ﹤0.01% 3538
2021
Q4
$1.02M Buy
106,900
+8,390
+9% +$79.7K ﹤0.01% 2624
2021
Q3
$1.67M Buy
98,510
+58,520
+146% +$989K ﹤0.01% 2230
2021
Q2
$1.12M Buy
+39,990
New +$1.12M ﹤0.01% 2617
2021
Q1
Sell
-31,836
Closed -$462K 3566
2020
Q4
$462K Buy
31,836
+9,136
+40% +$133K ﹤0.01% 2855
2020
Q3
$341K Sell
22,700
-9,262
-29% -$139K ﹤0.01% 2952
2020
Q2
$662K Buy
31,962
+8,492
+36% +$176K ﹤0.01% 2762
2020
Q1
$446K Buy
23,470
+11,560
+97% +$220K ﹤0.01% 2814
2019
Q4
$343K Buy
+11,910
New +$343K ﹤0.01% 3037